NPCE
Neuropace IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$498.27M
P/E Ratio
—
EPS
$-0.66
Beta
1.88
52W High
$18.98
52W Low
$7.56
50-Day MA
$14.52
200-Day MA
$12.52
Dividend Yield
—
Profit Margin
-21.50%
Forward P/E
—
PEG Ratio
—
About Neuropace Inc
NeuroPace, Inc. is a medical device company in the United States. The company is headquartered in Mountain View, California.
Fundamentals
| Revenue (TTM) | $99.99M |
| Gross Profit (TTM) | $77.22M |
| EBITDA | $-16.10M |
| Operating Margin | -6.65% |
| Return on Equity | -158.70% |
| Return on Assets | -10.20% |
| Revenue/Share (TTM) | $3.06 |
| Book Value | $0.57 |
| Price-to-Book | 25.91 |
| Price-to-Sales (TTM) | 4.98 |
| EV/Revenue | 5.03 |
| EV/EBITDA | -16.94 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 23.90% |
| Shares Outstanding | $33.67M |
| Float | $22.86M |
| % Insiders | 2.68% |
| % Institutions | 95.00% |
Analyst Ratings
Consensus ($19.88 target)
1
Strong Buy7
BuyData last updated: 4/9/2026